Member Info for Dustbin101

What is astonishing is just about all the other 99 products on the list are being used today by consumers and hence, are being searched online .

Zenakine will go nuts when it actually hits the shelf any day soon. .!!

17th position just from within the cosmetic industry is fantastic

Now we know why Croda are so upbeat , with a very strong up take, being backed up , from yet another source .

Https://www.trendhunter.com/slideshow/july-2025-cosmetics

The timing of updates has zero bearing on Zenakine sales.

EV sales

Market Share:

Electric vehicles, including both BEVs and plug-in hybrids, have steadily gained market share. In May 2024, 17.6% of new car registrations were electric cars.

————————————————————————————————————————-

It has taken ten years for the EV market to gain a 17.6% of car sales.

Two reasons

Poor range and price.

——————————————————————————————————————————‘

Now I put it to investors :

What adoption rate should we expect from Zenakine : ?

Here, we are replacing oil based ingredients with clean and sustainable bio.

The product concentration can vary from 0.3% to 3%

Zenakine outperforms by a mile

Zenakine is cheap to produce ( cold formulated )

——————————————————————————————————————————

Conclusion :

EV sales hit a brick wall with most consumers

Zenakine is embraced by all :

The industry, and the consumer, price can be adjusted through the amount used in each end product.

No issues in increasing production to match sales of Zenakine

Zenakine not only replaces older dirty products , it also creates new markets.

Unlike a car the average consumer buys cosmetics several times a year and never stops that pattern of spending.

More sticky than Mr Humble .!!!!

Great find, the yanks love to sniff out the next potential 100 bagger for their clients

One can see Croda grabbing all the market with its 3 plus year head start .!!

What fun.!!

Not late with results, has until 31/12/25

Your waiting on a full year trading statement due end of July / early Aug

A broker has freedom , it’s his best guess.

If I was Ashman I would be fine

Start low and build

Standard practise in the world of.Client brokering

Take 100 companies

Find a first broker note followed by a second one that’s a downgrade on the fist .!!!

Report back

Ta

Don’t be SO silly , brokers write what they like, CRODA has over ten , does the FD ring ring round all ten after each publish a research note

NO

Look at the 2025 trends

Zenakine right place right time

Hence as Croda has reported last week , flying out of the door ,!!!

10 Realities of Beauty M&A in 2025:

1. Strategic Acquisitions Are on the Rise

Major players like L’Oreal, and Unilever are expanding their portfolios through acquisitions of innovative beauty and personal care brands, signaling strong interest in growth-driven M&A activity.

2. Wellness Is Driving Investment

The convergence of beauty, personal care, and wellness is reshaping the market, with brands that integrate wellness principles gaining significant traction among both consumers and investors.

3. Innovation Matters

Unique, science-backed, or patented products, such as Tangle Teezer’s detangling brushes, are highly attractive to strategic buyers for their distinct value propositions.

4. Consumer Values Are Key

Brands that align with consumer priorities—such as sustainability, natural ingredients, or long-term health benefits—are better positioned to secure investment.

***. The prime issue (at least it would be for funds that include regulatory risk in their models): without full clarity on this, you could easily be exposed to 1-2 years of RNS's rattling on about volumes or clients, and be wholly exposed to a negative shock at launch re what is on the labelling. ***

What a heap of rubbish .!!!!

Zenakine is roaring out of the door .!!!

Are you saying heaps of worldwide clients, are buying a premium product to put in the rubbish bin. .!!!

Yep lots missed by investors inc

So in Beauty, we're seeing the rise of regional giants, companies like Boticario and Quala in Brazil, Arma in Egypt, Kolmar in Korea and Milbon in Japan. We are replicating our successful China model to help these key players in the market grow and in Consumer Care. Our sales to local and regional customers increased 11% in constant currency and they now represent 81% of sales up from 72% in 2019.

We are seeing structural change

Yes, net, the results get better over time with Zenakine as well as per the presentation after the SBTX Zenakine launch in April

Morning :

Confirmed to be Zenakine

“ we've seen a very fast uptake for a new product. “

/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

When a FTSE 100 company makes that statement it’s worth its weight in Gold.

Why :

Repeat orders for decades will provide SBTX with massive growing revenues, for perhaps, decades.( just like Matrixyl )

As we can see from this massive take up in the market today, no one can get near it, if you’re a cosmetic company , you go green and sustainable in one hit , to save costs.

Then you stick

It’s now or never, sales over the last 3months have shown us **** it’s now ***. !!!

You have not understood

The MM are now all making a market

This was not the case last month.

MM gone 2 V1

What’s changed. ?

Unlike the last month or two when just one MM was running the book it’s now an open field

Looking more like overhang has gone this morning

Just 1 market maker left on the offer

Yep , overhang appears to have been eaten alive .!!

Today will tell

Utter rubbish

Croda clear 17p in the pound pure profit